June 26, 2013

Press Release No. 1

News about Madhucon Projects Limited

The media had reports that Madhucon Projects Limited is in process to raise funds by selling stake in its road projects.

The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company.

Madhucon Projects Limited has vide its letter inter-alia stated that, "The Bloomberg interviewer was informed:

1. Madhucon Group debt including Road projects and Power project is approximately Rs. 4800 crores.

2. During the last one year efforts are being made to monetize the operational road assets and also power assets in order to raise funds. Merchant bankers have also been appointed for this purpose.

3. It has also been informed that The Company will postpone the bidding of BOT road projects for some more time."

Press Release No. 2

News about Elder Pharmaceuticals Limited

The media had reports that Elder Pharmaceuticals Limited is in process to sell its domestic formulation business.

The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company.

Elder Pharmaceuticals Limited has vide its letter inter-alia stated, "As informed earlier, at this stage the company does not have any definite proposal for sale of its domestic formulations business. The Company has been looking for opportunities of organic and inorganic growth / strategic partnerships /restructuring / fund raising activities, etc, so as to add value to the shareholders. We, as a company constantly work towards adding value to our shareholders and for growth of the Company. We have not received any non-binding offers from counter parties as mentioned in the article reported by media today. The Company will need to place any proposals received before its board of directors for their consideration. As and when the board approves any of the proposals, and there is more information for any potential transaction, which could have bearing on the operations/ performance of the company or are price sensitive, we will inform the exchange in accordance with the Listing Agreement."

Press Release No. 3

Clarification by Ankur Drugs And Pharma Limited

Significant price movement has been observed in Ankur Drugs And Pharma Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Ankur Drugs And Pharma Limited has vide its letter inter-alia stated, "In this connection we have to advice that no activity influencing the price movement of scrip is taking place in the Company. The volatility in the movement of the scrip price is purely market driven and Company in nowhere involved in the same."